KARACHI: Lucky Core Industries (LCI) has acquired Pfizer Pakistan Limited's manufacturing facility under the Asset Purchase Agreements entered into between the parties.
Along with this, LCI has also acquired the products and product registrations consisting of Ansaid, Ponstan, Ponstan Forte, Basoquin, Deltacortril, Lysovit, Corex-D and Mycitracin.
The LCI announced that the asset acquisition has successfully been completed on September 06, 2024 in accordance with the Asset Purchase Agreement entered into between the parties.
Copyright Business Recorder, 2024
Comments
Comments are closed.